Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol-based total intravenous anesthesia in end-stage renal disease patients
KCT0007790Phase 4Not yet recruiting
- Sponsor
- National Research Foundation
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of propofol in end-stage kidney disease (ESKD), sponsored by National Research Foundation. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
propofol
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on KCT0007790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0007790.